Immatics (IMTX) Payables (2019 - 2026)
Immatics (IMTX) posted Payables of $21.9 million for Q4 2025, down 16.78% sequentially from $26.3 million in Q3 2025, and down 0.86% YoY from $22.1 million in Q4 2024.
Analysis
Immatics (IMTX) Payables (2019 - 2026) Analysis & Trends
Immatics has reported Payables for 7 years, with the latest figure at $21.9 million in Q4 2025.
- Quarterly Payables fell 0.86% year-over-year to $21.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $21.9 million (down 0.86% YoY) and the FY2025 annual result came in at $21.3 million, down 5.0% from the prior year.
- Payables fell to $21.9 million in Q4 2025 per IMTX's latest filing, from $26.3 million in the prior quarter.
- Over five years, Payables peaked at $27.1 million in Q4 2023 and troughed at $11.3 million in Q2 2021.
- A 5-year average of $18.5 million and a median of $19.8 million in 2024 frame the typical range for Payables.
- The sharpest annual moves came in 2023 and 2024: Payables soared 103.6% in 2023, then dropped 18.46% in 2024.
- Over 5 years, Payables stood at $13.3 million in 2021, then increased by 0.17% to $13.3 million in 2022, then jumped by 103.6% to $27.1 million in 2023, then fell by 18.46% to $22.1 million in 2024, then declined by 0.86% to $21.9 million in 2025.
- According to Business Quant data, Payables over the past three periods registered $21.9 million, $26.3 million, and $21.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 167.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 88.42 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 470.30 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 108.02 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 35.57 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Immatics | 1.17 Bn | 711.21 Mn | - | 38.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38.54 Mn |
| Mar 31, 2026 | 36.97 Mn |
| Dec 31, 2025 | 21.92 Mn |
| Sep 30, 2025 | 26.34 Mn |
| Jun 30, 2025 | 21.17 Mn |
| Mar 31, 2025 | 19.35 Mn |
| Dec 31, 2024 | 22.11 Mn |
| Sep 30, 2024 | 24.27 Mn |
| Jun 30, 2024 | 20.24 Mn |
| Mar 31, 2024 | 22.31 Mn |
| Dec 31, 2023 | 27.12 Mn |
| Sep 30, 2023 | 21.59 Mn |
| Jun 30, 2023 | 21.67 Mn |
| Mar 31, 2023 | 15.37 Mn |
| Dec 31, 2022 | 13.32 Mn |
| Sep 30, 2022 | 12.93 Mn |
| Jun 30, 2022 | 14.17 Mn |
| Mar 31, 2022 | 14.93 Mn |
| Dec 31, 2021 | 13.30 Mn |
| Sep 30, 2021 | 13.97 Mn |